Alex Dimitriu
Psychiatry · Menlo Park, CANPI 1184882037
Payments from drug & device makers
Across 147 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- Takeda Pharmaceuticals U.S.A., Inc.$344
- Axsome Therapeutics, Inc.$338
- Jazz Pharmaceuticals Inc.$313
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$311
- Vanda Pharmaceuticals Inc.$111
- plus $516 from 10 others
What the payments were for
- Food & beverage$2,660100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $727 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $344 |
| Axsome Therapeutics, Inc. | 13 | $338 |
| Jazz Pharmaceuticals Inc. | 12 | $313 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $311 |
| Vanda Pharmaceuticals Inc. | 6 | $111 |
| Eisai Inc. | 2 | $91 |
| Neurocrine Biosciences, Inc. | 2 | $65 |
| Sunovion Pharmaceuticals Inc. | 3 | $64 |
| Johnson & Johnson | 3 | $63 |
| Lundbeck LLC | 4 | $52 |
| Shire North American Group Inc | 4 | $51 |
| Harmony Biosciences LLC | 1 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Corium, LLC | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUNOSI$125
How this compares
$2,660 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 69 | $3,282 |
| Duloxetine Hcl | 33 | $1,432 |
| Lamotrigine | 44 | $641 |
| Mirtazapine | 16 | $583 |
| Bupropion XlBupropion Hcl | 36 | $564 |
| Quetiapine Fumarate | 23 | $501 |
| Zaleplon | 20 | $420 |
| Valproic Acid | 12 | $409 |
| Citalopram HbrCitalopram Hydrobromide | 24 | $377 |
| Zolpidem Tartrate ErZolpidem Tartrate | 12 | $352 |
| Gabapentin | 24 | $331 |
| Sertraline Hcl | 31 | $288 |
| Lithium Carbonate | 19 | $273 |
| Trazodone Hcl | 12 | $234 |
| Lithium Carbonate ErLithium Carbonate | 12 | $204 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Menlo Park
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.